Figure 6From: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis Meta-analysis examining preoperative chemoradiation and surgery compared to surgery alone: mortality at one year. Overall risk ratio = 0.89 (95% CI, 0.76 to 1.03; p = 0.12)Back to article page